Perpetual Traffic – Episode Summary

Episode Title:

How to Crush It With GLP-1s & TRTs on Meta Using “The Sticky Pixel Strategy”

Hosts:

• Ralph Burns (Tier 11 CEO)
• John Wood (Performance Marketing Strategist)

Date:

January 16, 2026

Overview

This episode dives deep into a fresh and high-performing strategy for scaling Meta (Facebook/Instagram) ads in ultra-competitive health niches: specifically GLP-1s (weight loss peptides) and TRT (Testosterone Replacement Therapy). Ralph and John break down “The Sticky Pixel Strategy,” an approach born out of real-world campaign scaling—showing how to leverage creative diversification and new Meta algorithm behaviors (“Andromeda” and “Gem”) to acquire prescription customers at record-low CPAs, even when old-school tactics no longer work.

The conversation is packed with actionable case studies, explanations of evolving ad platform logic, and a candid, data-driven look at what’s working now as pixel-based targeting and broad audiences continue to change the game for performance marketers.

Key Discussion Points

1. What is the “Sticky Pixel” Strategy?

[04:23]

• John introduces “Sticky Pixel”: Instead of traditional audiences, Meta now aggregates a “core group” dried directly from long-term pixel history across the entire ad account.
• This “cloud” becomes your default audience. New campaigns, creatives, and testing efforts mostly re-target those who've already interacted with you, rather than unlocking new, cold prospects.
• "Meta is doing everything it can to keep [users] there. It’s trying to not let them go." – John [06:04]
• Broadly similar to Google’s Performance Max/Demand Gen campaigns. Algorithms have evolved to prioritize campaign-level learning and existing audience clouds over manual segmentation.

2. The Case Study: Scaling Prescriptions for Peptides & TRT

[09:33]

• A health company scaled one campaign since Sept 2025 ($563k spend, 32K leads), relying on “We’re cheap/inexpensive” messaging for peptide prescriptions.
• Leads sent to an old-school consult: request, sales-call, doctor, prescription.

Observations:

• [14:26] The focus on price-only messaging filled the funnel with low-quality, unqualified leads (many forgot why the sales team was calling, unsure about the brand, or suspicious of too-good-to-be-true offers).
• Ralph: “One in a hundred… actually buys. So you need a secondary strategy to convince them to take the next step.” [16:02]
• Sales team feedback/rejection reasons formed the basis for evolving creative: “Seems too good to be true,” “Are you legit?”, “Where do medications come from?”

3. The New Creative Approach: Brand Sequencing over “Spray and Pray”

[19:16, 20:43]

• You can’t just throw five new concepts and see what sticks. Low-spend ‘test’ creative only muddles messaging for the core sticky audience.
• Key insight: Treat the “sticky pixel” audience as moving along a brand journey. Sequentially evolve creative and messaging, focusing on objection-killer content.

  “You have to almost pause in your brain. It’s not a traffic issue yet, it’s not even a creative issue yet. It’s a branding message now.” – John [19:32]

• Quality-focused messaging rolled out—addressing product legitimacy (where medications come from, real doctors, safety).

4. How Meta Targeting Actually Works Now (Broad Targeting Wins)

[21:12–25:36]

• Broad, open targeting is now outperforming tightly segmented or retargeting campaigns.
• Example: TRT campaign technically targeted men & women, but Meta algorithm autonomously weighted delivery 92% to men—perfect alignment with demographic intent.

  “Your targeting is now a suggestion. This is the part people can’t wrap their head around.” – John [25:36]

• Old-school "move them down the funnel" retargeting? Not necessary. Broad campaigns + creative addressing next objection provides both new customer acquisition and reactivation of engaged users.

5. Results & Tactical Breakdown

[27:41–34:03]

• By strictly sequencing creative (cheap → legit/objection-killing → transformational/status), the account saw dramatic CPA drops:
  • Cost per prescription customer: Down from ~$268 to $39 in a single week.
  • 800+ new customers acquired in one week.
  • Top ads directly address main objections (“Is this with a real doctor? Seems kind of shady?”).
    • “Objection killer ads” perform best—directly sourced from sales and support FAQs.
    • “It’s not out of happenstance that the majority of the users in the main kind of two big campaigns all want to know: ‘Is this shit legit?’” – John [30:34]
• Ramping up ad spend rapidly, with plans to take campaigns from $6K/day to $15K/day as performance continues to improve.
• Old “catch-all” campaigns losing utility; product-specific, objection-based creatives outperform and eventually absorb all the volume.

6. Broader Lessons & Strategy Evolution

[34:03–45:08]

• The “sticky pixel” model is how algorithms now function. Creative diversification and sequential brand messaging are key—creative is the new targeting.
• This approach feeds your Google/branded search performance, too: more Meta interactions lead to more efficient conversion on branded search.
• Meta and Google’s learning algorithms “know” user readiness better than manual targeting ever could.

  "You don't do any of that [manual sequencing] anymore. It’s all… you just skip the media buying portion… you still have to follow the process." – John [34:46]

• Systematic objection addressing/brand building results in “rising tides for all ships”—Meta drives volume, credibility primes Google Search.

Notable Quotes & Memorable Moments

• “Meta is doing everything it can to keep [those users] there. It’s trying to not let them go… Your campaigns, your creatives, the new ones, are just the next evolution of communication to the users that are stuck in your audience, because you have a sticky pixel.”
  – John [06:04]

• “If you get roped in by ‘hey, it’s cheap,’… at the point where you’re going to have to inject this in your body, are we sure this is legit? Because that’s a really inexpensive price.”
  – Ralph [14:52]

• “It’s not a traffic issue, not even a creative issue. It’s a branding message now.”
  – John [19:32]

• “Your targeting is now a suggestion. This is the part people can’t wrap their head around.”
  – John [25:36]

• “We’re gaining new prescription customers at sub 50 bucks. This is fantastic in the first week because I didn’t do anything but make sure my brand messaging to the sticky pixel was in a logical sequence to a sale.”
  – John [27:48]

• “Objection killer ads perform the best. We’ve spent a half million dollars telling people it's cheap. What’s the next thing they’re going to say? ‘That sounds good. Is it any good?’ Very logical.”
  – John [30:34]

Important Timestamps

• [04:23] – What is the Sticky Pixel, and why “audience clouds” matter now
• [09:33] – Real campaign case study: half-million dollar ad spend
• [14:26] – Problem with price-only messaging: low-quality leads
• [16:02] – Why secondary education/objection handling is critical
• [19:32] – Why creative testing must be purposeful, not scattered
• [25:36] – Targeting as a “suggestion”; Meta does the sorting
• [27:41]/[27:48] – Results: CPA drops, customer acquisition spikes
• [30:34] – Objection-killer ads and creative structure
• [34:03] – Sequencing “sticky pixel” messaging; platform evolution insights
• [42:28] – Product-specific campaigns overtaking catch-alls
• [44:04] – Why search is now “clean-up,” not the main channel

Tone and Takeaways

Candid, expert, and data-driven, this episode dissects what modern media buying really looks like in strict-platform, regulated, or competitive verticals. The hosts highlight that technical levers are less important than strategic sequencing and meeting customers' current mindset along their journey—using algorithmic tools as accelerators rather than manual controllers.

For marketers and business owners:

• Focus on branding sequence and creative diversification, not micro-testing or manual retargeting.
• Use sales team/FAQ data to build “objection-killer” ads.
• Accept that broad targeting + creative is outperforming legacy “segmentation.”
• Leverage platform machine learning as your advantage, not as a liability.

Episode Resources

• For campaign resources, guides, and case studies: perpetualtraffic.com
• Sponsorship/contact: perpetualtraffic.com/apply

For anyone responsible for paid acquisition in 2026, this episode is an indispensable breakdown of not only what works, but why it works in an ever-evolving digital ad ecosystem.